- Home
- ZURA vs REFI Comparison
ZURA vs REFI Comparison
Compare ZURA & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- REFI
- Stock Information
- Founded
- ZURA 2022
- REFI 2021
- Country
- ZURA United States
- REFI United States
- Employees
- ZURA N/A
- REFI N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- REFI Real Estate Investment Trusts
- Sector
- ZURA Health Care
- REFI Real Estate
- Exchange
- ZURA Nasdaq
- REFI Nasdaq
- Market Cap
- ZURA 69.9M
- REFI 293.5M
- IPO Year
- ZURA N/A
- REFI 2021
- Fundamental
- Price
- ZURA $1.31
- REFI $13.95
- Analyst Decision
- ZURA Buy
- REFI Strong Buy
- Analyst Count
- ZURA 7
- REFI 3
- Target Price
- ZURA $14.33
- REFI $20.00
- AVG Volume (30 Days)
- ZURA 708.2K
- REFI 102.7K
- Earning Date
- ZURA 08-08-2025
- REFI 08-06-2025
- Dividend Yield
- ZURA N/A
- REFI 13.51%
- EPS Growth
- ZURA N/A
- REFI N/A
- EPS
- ZURA N/A
- REFI 1.88
- Revenue
- ZURA N/A
- REFI $56,790,054.00
- Revenue This Year
- ZURA N/A
- REFI $15.53
- Revenue Next Year
- ZURA N/A
- REFI $6.70
- P/E Ratio
- ZURA N/A
- REFI $7.40
- Revenue Growth
- ZURA N/A
- REFI 4.68
- 52 Week Low
- ZURA $0.97
- REFI $12.76
- 52 Week High
- ZURA $5.07
- REFI $16.47
- Technical
- Relative Strength Index (RSI)
- ZURA 59.63
- REFI 40.80
- Support Level
- ZURA $1.00
- REFI $13.85
- Resistance Level
- ZURA $1.45
- REFI $14.15
- Average True Range (ATR)
- ZURA 0.10
- REFI 0.25
- MACD
- ZURA 0.03
- REFI -0.01
- Stochastic Oscillator
- ZURA 68.89
- REFI 7.73
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.